Oesophageal Cancer Trial, Recruiting NCT07449208 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT07449208
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a confirmed cancerous tumour of the oesophagus (food pipe) that requires surgical removal of part or all of the oesophagus.
  • People who have one or more risk factors that increase the chance of a complication called an anastomotic leak (where the surgical join between the oesophagus and stomach does not heal properly). These risk factors include: previous stomach surgery such as a gastric sleeve or gastric bypass (but not fundoplication alone); a type of complex repeat surgery called salvage esophagectomy; a planned surgical join made at the neck rather than the chest; or having two or more of the following conditions: diabetes, obesity, coronary artery disease, vascular (blood vessel) disease, steroid use, high blood pressure, current or past smoking, kidney problems, or heart failure.
  • People who have agreed to undergo a preparatory procedure on the stomach before the main surgery (called gastric preconditioning).
  • People aged 18 or older.
  • People who are reasonably well and able to carry out daily activities, based on a standard medical assessment scale (confirm with trial site).
  • There are no restrictions based on previous cancer treatments received.

Who may not be able to join:

  • No specific exclusion criteria were listed in the source information provided (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniela Molena, MD, Memorial Sloan Kettering Cancer Center

Phone: 212-639-3870

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 February 2026
Est. completion
25 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of anastomotic leak

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov